LANSING, MI (Toledo News Now) – The Michigan Department of Community Health has been investigating the employment history of a hepatitis C-positive healthcare worker, who was arrested recently in New Hampshire for allegedly obtaining injectable narcotics and infecting patients with the hepatitis C virus.
Hepatitis C is a bloodborne viral infection, estimated to infect 1.6 percent of the U.S. population. It can cause inflammation of the liver, which may lead to chronic health issues. Most infected individuals do not know they have the virus because it can damage the liver for many years with few noticeable symptoms.
MDCH has confirmed that this individual previously worked in at least six Michigan facilities from 2003-2007 and is known to have been infected with hepatitis C since at least June 2010. The investigation has not uncovered evidence that the individual was infected with hepatitis C while employed at any Michigan facility. A negative hepatitis C test result at one hospital during his employment allows MDCH to exclude two hospitals from further examination, as there was no risk posed by this individual to patients at the facilities.
MDCH recommends that all individuals with known risk factors for hepatitis C virus be tested. Any patients who visited one or more of the facilities listed below during the identified time periods and received an injectable narcotic, may have a risk factor of which they were previously unaware. They should consult the facility contact identified below and/or primary care provider regarding hepatitis C testing.
While the receipt of an injectable narcotic at these facilities during these time frames may represent a possible increased risk for hepatitis C for patients, it is clearly not the only risk. If patients do not know if an injectable narcotic was administered to them, they should contact the facility to find out more information. While this testing is important, it need not be considered an emergency procedure.
"Hepatitis C is a chronic condition that can damage the liver for many years without noticeable symptoms," explained Dean Sienko, interim chief medical executive of the MDCH. "Our goal of recommending testing is to ensure the appropriate use of the modern medicine, now available, to prevent deaths from hepatitis. In order to help potentially affected individuals, we are asking patients to get tested to protect their health."
Due to the length of time, since potential exposure as well as the prevalence of the disease in the general population, a positive test result for patients of the facilities may not conclusively prove that hepatitis C was acquired from the individual currently under investigation at these facilities.
The Centers for Disease Control and Prevention estimates that more than 2 million U.S. citizens, born from 1945 through 1965, have been infected with the virus and is currently recommending testing for everyone born in that time frame. Hepatitis C can be detected with blood tests and treated with antiviral medications.
Identified Michigan hospitals, dates of interest, and facility contact information:
Because this is an ongoing investigation, MDCH will continue to identify past employment history and work with all identified facilities in Michigan, as well as the CDC. The MDCH will provide any updates to this information as it becomes available. For questions and information about hepatitis C, visit MDCH, the CDC or Detroit Medical Center.
Copyright 2012 Toledo News Now. All rights reserved.
730 North Summit Street